PolarisQB advances drug safety prediction with quantum-inspired AI, enabling early removal

DURHAM, NC - Polaris Quantum Biotech has been selected as a

DURHAM, NC - Polaris Quantum Biotech (PolarisQB), a leader in

DURHAM, NC - The Defense Advanced Research Projects Agency (DARPA)

DURHAM, NC - Polaris Quantum Biotech (PolarisQB), a leader in

Introduction Computational drug design typically requires a well-defined protein-ligand complex.

Introduction The DARPA IMPAQT ARC Opportunity solicited ideas to

Introduction Fragment-based drug design (FBDD) uses molecular fragments to identify

Introduction Inhibiting Protein-Protein Interactions (PPIs) with small molecules is

On Tuesday, October 1, PolarisQB hosted a webinar titled "Find

OpenFold, a leading non-profit artificial intelligence (AI) research consortium focused on

PolarisQB is happy to announce the integration of Virtual Libraries and

Quantum-Aided Drug Design (QuADD) is delivering value to our customers

On Friday, May 17, PolarisQB hosted a group of thought

POLARISqb, a company revolutionizing drug design by joining quantum computing

POLARISqb, the first company to build quantum-enabled molecular optimization tools

Polaris Quantum Biotech (PolarisQB), the leader in quantum computing-based drug

The Defense Advanced Research Project Agency (DARPA) awarded POLARISqb a

PolarisQB, the first company in the world to develop a drug

At Polaris Quantum Biotech, we’re leveraging quantum computing to accelerate drug discovery.